T. Rowe Price Health Care ETF Rating $35.17 -0.07 (-0.20%) As of 02:57 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsTrendsBuy This Stock T. Rowe Price Health Care ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.TMED Aggregate RatingModerate Buy 2.81Holdings in TMED have an aggregate rating of Moderate Buy based on 520 analyst ratings issued in the past year covering 25 companies (74.5% of the portfolio).TMED Aggregate Price Target$35.16-0.03% DownsideHigh Prediction$35.16Average Prediction$35.16Low Prediction$35.16Holdings in TMED have an aggregate price target of $35.16 and a range of $35.16 to $35.16 covering 25 companies (74.5% of the portfolio).TMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by T. Rowe Price Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 TMED Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.75%LLYEli Lilly and Company$1,182.24-2.2%4.732 of 5 stars2.83$1,292.18 9.3%30Trending NewsAnalyst DowngradeInsider TradeAnalyst Revision5.60%UNHUnitedHealth Group$401.53+0.6%4.9358 of 5 stars2.89$455.92 13.5%27Dividend Announcement4.52%ALNYAlnylam Pharmaceuticals$228.65+0.7%4.8293 of 5 stars2.92$393.86 72.3%24Analyst Forecast4.37%TMOThermo Fisher Scientific$588.17-1.3%4.6535 of 5 stars2.79$619.41 5.3%24Insider Trade3.36%CORCencora$313.86+1.2%4.9539 of 5 stars2.87$374.25 19.2%15Analyst Forecast3.10%PODDInsulet$143.34-2.1%4.8449 of 5 stars2.44$195.40 36.3%27Trending News3.05%GILDGilead Sciences$138.36+0.2%4.4449 of 5 stars2.83$158.04 14.2%29Trending NewsAnalyst DowngradeOptions VolumeAnalyst Revision2.93%DHRDanaher$202.51-0.7%4.4043 of 5 stars2.84$228.91 13.0%252.68%AAgilent Technologies$148.55-0.5%4.7795 of 5 stars2.89$160.24 7.9%19Positive NewsAnalyst Forecast2.61%DYNDyne Therapeutics$25.70-1.0%3.7468 of 5 stars2.87$34.42 33.9%15Positive News2.42%DXCMDexCom$89.75-1.9%4.2088 of 5 stars2.89$88.71 -1.2%27Analyst Upgrade2.37%SYKStryker$338.80-0.7%4.8793 of 5 stars2.79$386.28 14.0%24Positive NewsAnalyst Downgrade2.28%WSTWest Pharmaceutical Services$348.94+0.8%3.8871 of 5 stars2.87$368.08 5.5%15Trending NewsAnalyst DowngradeAnalyst Revision2.27%WATWaters$411.88-0.4%2.7427 of 5 stars2.75$420.35 2.1%20Analyst Downgrade1.76%BSXBoston Scientific$51.77+0.1%4.941 of 5 stars2.71$71.62 38.3%31Trending NewsGap Up1.72%IMNMImmunome$27.20+3.0%2.8465 of 5 stars2.85$34.64 27.3%13Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision1.71%MCKMcKesson$868.72+1.4%4.9169 of 5 stars2.82$977.00 12.5%17Analyst ForecastInsider Trade1.56%CYTKCytokinetics$74.13+0.9%3.5587 of 5 stars2.86$102.20 37.9%21Analyst ForecastAnalyst Revision1.45%PCVXVaxcyte$58.07-1.3%2.2349 of 5 stars2.50$86.00 48.1%8Positive NewsAnalyst Upgrade1.42%BIIBBiogen$209.83-0.4%4.0032 of 5 stars2.58$227.07 8.2%33Analyst Downgrade1.39%IDXXIDEXX Laboratories$550.96-2.8%4.7171 of 5 stars2.60$747.00 35.6%10Positive NewsAnalyst Forecast1.34%ASNDAscendis Pharma A/S$248.50+0.9%4.502 of 5 stars3.06$299.24 20.4%18News CoverageEarnings ReportAnalyst Forecast1.31%ELANElanco Animal Health$23.64+5.0%4.2934 of 5 stars2.77$29.09 23.1%13Insider TradeGap Up1.27%DNLIDenali Therapeutics$24.40-1.7%2.7178 of 5 stars2.75$35.92 47.2%16News CoverageAnalyst Revision1.24%BNTXBioNTech$93.09+1.1%3.3359 of 5 stars2.74$127.81 37.3%19 This page (NASDAQ:TMED) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredOne wafer-scale chip does in minutes what AI takes daysNVIDIA has dominated the AI computing race, but history shows even titans can be dethroned, just ask IBM. T...Eagle Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T. Rowe Price Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share T. Rowe Price Health Care ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
